Continuous-flow (CF) left ventricular assist devices (LVADs) have revolutionized the
management of patients with end-stage heart failure, increasing access and improving …

Over the course of the last decade, implantation of left ventricular assist devices (LVADs)
has become an increasingly popular treatment strategy for patients with advanced heart …

Background Continuous-flow left ventricular assist devices (CF-LVADs) have become the
standard of care for patients with end-stage heart failure (HF). While these devices have …

Continuous-flow (CF) left ventricular assist device (LVAD) therapy for patients with advanced
heart failure continues to increase both as a bridge to transplant (BTT) and as destination …

Continuous-flow left ventricular assist devices (CF-LVADs) have significantly improved
outcomes for patients with end-stage heart failure when used as a bridge to cardiac …

Purpose The use of left ventricular assist devices (LVAD) for the treatment of end-stage heart
failure is becoming more common. Evidence suggests that patients treated with continuous …

Gastrointestinal bleeding (GIB) is a common adverse event after continuous‐flow left
ventricular assist device (CF‐LVAD) implantation. We sought to evaluate patterns of GIB …

Background Modern left ventricular assist devices (LVAD) require anti-coagulation (AC) with
warfarin and anti-platelet therapy to prevent thromboembolic complications in patients …

How to prevent gastrointestinal bleeding in the high-risk patients following left ventricular assist
device implantation. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Gastrointestinal bleeding is one of the most common complications in patients with
continuous-flow left ventricular assist devices. Though the exact pathophysiology is still …